Bloomberg Intelligence cover image

Novo Nordisk Gets US Approval for Wegovy Obesity Pill 

Bloomberg Intelligence

00:00

Competition with Eli Lilly and strategy

Hosts ask how Novo will compete with Lilly's oral candidate and Lars outlines efficacy and safety advantages.

Play episode from 03:20
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app